Anti-inflammatory and anti-aging cosmetic for use after medical aesthetic procedure

A liquid composite, comprising:

• an active ingredient and water, wherein a content of the active ingredient in the liquid composite is 0.003-6.0 wt %;
• the active ingredient comprises an active substance that comprises at least one of acetyl hexapeptide-8, oligopeptide-1, dipeptide diaminobutyroyl benzylamide diacetate, carnosine, palmitoyl tripeptide-1, palmitoyl tripeptide-5, ACE liposome, and bifida ferment lysate;
• the active ingredient further comprises an active agent that comprises a succinate derivative and propane-1,2-diol alginate;
• the succinate derivative is prepared by:
• adding sodium hydroxide and 2-aminoethyl hydrogen sulfate to deionized water, and mixing with stirring;
• then adding a maleate and ethanol at 30-50° C. and reacting for 2-8 h;
• after the reaction is completed, cooling to form a precipitate;
• and carrying out filtration, washing, and distillation under reduced pressure to obtain the succinate derivative, wherein the sodium hydroxide is used in an amount of 30-50 wt % of the deionized water, while the 2-aminoethyl hydrogen sulfate is used in an amount of 40-60 wt % of the deionized water and in an amount of 20-30 wt % of the maleate, and absolute ethanol is used in an amount of 100-200 wt % of the maleate;
• the maleate is prepared by:
• adding trimethylolpropane to maleic anhydride at 60-80° C., and reacting at 85-95° C. for 2-8 h;
• and after the reaction is completed, obtaining the maleate, wherein the trimethylolpropane is used in an amount of 50-150 wt % of the maleic anhydride;
• a content of the active agent in the liquid composite is 0.003-1.0 wt %;
• or, a content of the active substance in the liquid composite is 0.003-5.0 wt %.